OTC Markets OTCPK - Delayed Quote USD
Livzon Pharmaceutical Group Inc. (LVZPF)
3.4300
0.0000
(0.00%)
At close: May 7 at 4:00:00 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
24,455,825.6972
25,044,827.1278
24,868,169.4176
22,371,915.5908
Total Liabilities Net Minority Interest
9,550,079.1031
10,278,124.1317
9,931,885.1182
8,060,890.7972
Total Equity Gross Minority Interest
14,905,746.5940
14,766,702.9960
14,936,284.2994
14,311,024.7936
Total Capitalization
15,328,069.3017
15,655,268.5817
15,850,513.4481
13,640,543.8843
Common Stock Equity
13,862,334.1893
14,042,495.3027
13,876,069.4052
13,003,763.6315
Capital Lease Obligations
13,102.5277
9,030.6226
11,607.9984
5,274.2408
Net Tangible Assets
13,113,243.0390
13,203,412.1203
12,946,636.6219
12,065,944.3919
Working Capital
8,794,552.2725
9,179,037.2435
9,590,632.1201
7,748,028.5274
Invested Capital
17,783,069.3017
17,515,278.2067
17,472,753.3080
15,683,591.9080
Tangible Book Value
13,113,243.0390
13,203,412.1203
12,946,636.6219
12,065,944.3919
Total Debt
3,982,579.7261
4,141,493.0039
3,618,732.8635
2,694,386.8532
Share Issued
911,345.7300
923,938.1390
935,552.6870
937,865.1210
Ordinary Shares Number
911,345.7300
923,938.1390
935,552.6870
937,865.1210
12/31/2021 - 6/29/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade